4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-046807
Chairman and CEO bought 5,300 shares at an average $1.51 ($7,986)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-07-13 | Purchase | +1,800 | $1.52 | $2,736 | 10,789,371 | D |
| Niihara Yutaka Chairman and CEO | 2021-07-14 | Purchase | +1,300 | $1.50 | $1,950 | 10,790,671 | D |
| Niihara Yutaka Chairman and CEO | 2021-07-15 | Purchase | +2,200 | $1.50 | $3,300 | 10,792,871 | D |
| Open-market purchases · 5,300 sh · avg $1.51 · $7,986 | |||||||
Loading xslF345X03/doc4.xml…